Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Pieter J Visser"'
Autor:
Marta del Campo, Carlos Quesada, Lisa Vermunt, Carel F. W. Peeters, Yanaika S. Hok-A-Hin, Calvin Trieu, Anouk den Braber, Inge M. W. Verberk, Pieter J. Visser, Betty M. Tijms, Wiesje M. van der Flier, Charlotte E. Teunissen
Publikováno v:
Molecular Neurodegeneration, Vol 19, Iss 1, Pp 1-5 (2024)
Abstract This preclinical AD CSF proteome study identified a panel of 12-CSF markers detecting amyloid positivity and clinical progression to AD with high accuracy; some of these CSF proteins related to immune function, neurotrophic processes, energy
Externí odkaz:
https://doaj.org/article/02bf197ce2e0447abfb8c9d7bd7ba96c
Autor:
Kaja Nordengen, Bjørn-Eivind Kirsebom, Grit Richter, Lene Pålhaugen, Berglind Gísladóttir, Nikias Siafarikas, Arne Nakling, Arvid Rongve, Geir Bråthen, Gøril Rolfseng Grøntvedt, Fernando Gonzalez, Knut Waterloo, Kulbhushan Sharma, Thomas Karikari, Eleonora M. Vromen, Betty M. Tijms, Pieter J. Visser, Per Selnes, Milicia G. Kramberger, Bengt Winblad, Kaj Blennow, Tormod Fladby
Publikováno v:
Journal of Neuroinflammation, Vol 20, Iss 1, Pp 1-16 (2023)
Abstract Background Brain innate immune activation is associated with Alzheimer’s disease (AD), but degrees of activation may vary between disease stages. Thus, brain innate immune activation must be assessed in longitudinal clinical studies that i
Externí odkaz:
https://doaj.org/article/e8a9047557934ffca73d41a8657fb122
Autor:
Giulia Quattrini, Michela Pievani, Jorge Jovicich, Marco Aiello, Núria Bargalló, Frederik Barkhof, David Bartres-Faz, Alberto Beltramello, Francesca B. Pizzini, Olivier Blin, Regis Bordet, Massimo Caulo, Manos Constantinides, Mira Didic, Antonios Drevelegas, Antonio Ferretti, Ute Fiedler, Piero Floridi, Hélène Gros-Dagnac, Tilman Hensch, Karl-Titus Hoffmann, Joost P. Kuijer, Renaud Lopes, Camillo Marra, Bernhard W. Müller, Flavio Nobili, Lucilla Parnetti, Pierre Payoux, Agnese Picco, Jean-Philippe Ranjeva, Luca Roccatagliata, Paolo M. Rossini, Marco Salvatore, Peter Schonknecht, Björn H. Schott, Julien Sein, Andrea Soricelli, Roberto Tarducci, Magda Tsolaki, Pieter J. Visser, Jens Wiltfang, Jill C. Richardson, Giovanni B. Frisoni, Moira Marizzoni
Publikováno v:
NeuroImage, Vol 218, Iss , Pp 116932- (2020)
Background: The amygdala and the hippocampus are two limbic structures that play a critical role in cognition and behavior, however their manual segmentation and that of their smaller nuclei/subfields in multicenter datasets is time consuming and dif
Externí odkaz:
https://doaj.org/article/4bcba99cf0714e6b976f984d5ac2cc2e
Autor:
Marta del Campo, Carel F. W. Peeters, Erik C. B. Johnson, Lisa Vermunt, Yanaika S. Hok-A-Hin, Mirrelijn van Nee, Alice Chen-Plotkin, David J. Irwin, William T. Hu, James J. Lah, Nicholas T. Seyfried, Eric B. Dammer, Gonzalo Herradon, Lieke H. Meeter, John van Swieten, Daniel Alcolea, Alberto Lleó, Allan I. Levey, Afina W. Lemstra, Yolande A. L. Pijnenburg, Pieter J. Visser, Betty M. Tijms, Wiesje M. van der Flier, Charlotte E. Teunissen
Publikováno v:
Nature aging, 2(11), 1040-+. Nature Publishing Group
del Campo, M, Peeters, C F W, Johnson, E C B, Vermunt, L, Hok-A-Hin, Y S, van Nee, M, Chen-Plotkin, A, Irwin, D J, Hu, W T, Lah, J J, Seyfried, N T, Dammer, E B, Herradon, G, Meeter, L H, van Swieten, J, Alcolea, D, Lleó, A, Levey, A I, Lemstra, A W, Pijnenburg, Y A L, Visser, P J, Tijms, B M, van der Flier, W M & Teunissen, C E 2022, ' CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels ', Nature Aging, vol. 2, no. 11, pp. 1040-1053 . https://doi.org/10.1038/s43587-022-00300-1
Nature Aging, 2(11), 1040-1053
Nature Aging, 2(11), 1040-1053. Springer
Nature Aging 2 (2022) 11
del Campo, M, Peeters, C F W, Johnson, E C B, Vermunt, L, Hok-A-Hin, Y S, van Nee, M, Chen-Plotkin, A, Irwin, D J, Hu, W T, Lah, J J, Seyfried, N T, Dammer, E B, Herradon, G, Meeter, L H, van Swieten, J, Alcolea, D, Lleó, A, Levey, A I, Lemstra, A W, Pijnenburg, Y A L, Visser, P J, Tijms, B M, van der Flier, W M & Teunissen, C E 2022, ' CSF proteome profiling across the Alzheimer’s disease spectrum reflects the multifactorial nature of the disease and identifies specific biomarker panels ', Nature Aging, vol. 2, no. 11, pp. 1040-1053 . https://doi.org/10.1038/s43587-022-00300-1
Nature Aging, 2(11), 1040-1053
Nature Aging, 2(11), 1040-1053. Springer
Nature Aging 2 (2022) 11
Development of disease-modifying therapies against Alzheimer's disease (AD) requires biomarkers reflecting the diverse pathological pathways specific for AD. We measured 665 proteins in 797 cerebrospinal fluid (CSF) samples from patients with mild co
Autor:
Aleksandra Maruszak, Edina Silajdžić, Hyunah Lee, Tytus Murphy, Benjamine Liu, Liu Shi, Chiara de Lucia, Abdel Douiri, Evgenia Salta, Alejo J Nevado, Charlotte E Teunissen, Pieter J Visser, Jack Price, Henrik Zetterberg, Simon Lovestone, Sandrine Thuret
Publikováno v:
Brain, 146(5), 2045-2058. Oxford University Press
Brain, 146, 2045-2058. Oxford University Press
Maruszak, A, Lee, H, Silajdzic, E, Murphy, T, Liu, B, Shi, L, De Lucia, C, Douiri, A, Salta, E, Nevado-Holgado, A J, Teunissen, C E, Jelle Visser, P, Price, J, Zetterberg, H, Lovestone, S & Thuret, S 2022, ' Predicting progression to Alzheimer’s disease with human hippocampal progenitors exposed to serum ', Brain . https://doi.org/10.1093/brain/awac472
Maruszak, A, Silajdžić, E, Lee, H, Murphy, T, Liu, B, Shi, L, de Lucia, C, Douiri, A, Salta, E, Nevado, A J, Teunissen, C E, Visser, P J, Price, J, Zetterberg, H, Lovestone, S & Thuret, S 2023, ' Predicting progression to Alzheimer's disease with human hippocampal progenitors exposed to serum ', Brain, vol. 146, no. 5, pp. 2045-2058 . https://doi.org/10.1093/brain/awac472
Brain, 146, 2045-2058. Oxford University Press
Maruszak, A, Lee, H, Silajdzic, E, Murphy, T, Liu, B, Shi, L, De Lucia, C, Douiri, A, Salta, E, Nevado-Holgado, A J, Teunissen, C E, Jelle Visser, P, Price, J, Zetterberg, H, Lovestone, S & Thuret, S 2022, ' Predicting progression to Alzheimer’s disease with human hippocampal progenitors exposed to serum ', Brain . https://doi.org/10.1093/brain/awac472
Maruszak, A, Silajdžić, E, Lee, H, Murphy, T, Liu, B, Shi, L, de Lucia, C, Douiri, A, Salta, E, Nevado, A J, Teunissen, C E, Visser, P J, Price, J, Zetterberg, H, Lovestone, S & Thuret, S 2023, ' Predicting progression to Alzheimer's disease with human hippocampal progenitors exposed to serum ', Brain, vol. 146, no. 5, pp. 2045-2058 . https://doi.org/10.1093/brain/awac472
Adult hippocampal neurogenesis is important for learning and memory and is altered early in Alzheimer's disease. As hippocampal neurogenesis is modulated by the circulatory systemic environment, evaluating a proxy of how hippocampal neurogenesis is a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b54607af71c847bfad2c81c38ab01838
https://cris.maastrichtuniversity.nl/en/publications/1167a72f-3597-4536-b944-c696ae5f4997
https://cris.maastrichtuniversity.nl/en/publications/1167a72f-3597-4536-b944-c696ae5f4997
Autor:
Daniel J. Panyard, Lianne M. Reus, Muhammad Ali, Jihua Liu, Yuetiva K. Deming, Qiongshi Lu, Gwendlyn Kollmorgen, Ivonne Suridjan, Norbert Wild, Pieter J. Visser, Lars Bertram, Henrik Zetterberg, Kaj Blennow, Johan Gobom, Dan Western, Yun Ju Sung, Cynthia M. Carlsson, Sterling C. Johnson, Sanjay Asthana, Carlos Cruchaga, Betty M. Tijms, Corinne D. Engelman, Michael P. Snyder
The recently reportedTNIP1/GPX3locus from AD GWAS studies was investigated. Using proteomics and other functional omics data, we identified evidence for a functional mechanism linking variants in this locus to decreased CSF GPX3 levels as AD progress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4540c9c4a76202a181299cbd6d9fcc3d
https://doi.org/10.1101/2022.11.04.22277162
https://doi.org/10.1101/2022.11.04.22277162
Autor:
Frans R J, Verhey, Pieter J, Visser
Publikováno v:
Nederlands tijdschrift voor geneeskunde. 157(11)
An increasing number of people with mild cognitive impairment (MCI) visits a memory clinic to find out whether their symptoms indicate Alzheimer's disease (AD). Markers in cerebrospinal fluid are increasingly used for the diagnosis of Alzheimer's dis